News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
18065
Sources here
21
Companies here
37
Search results Stored financial headlines

Active search

18065 matching headlines

Ticker or company: ADMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

JPMorgan downgrades PLDT stock on competitive pressure concerns

JPMorgan downgraded PLDT Inc. from Overweight to Neutral and reduced its price target due to competitive pressures limiting average revenue per user (ARPU) growth. The firm also lowered its fiscal year 2027 and 2028 earnings per share forecasts by 19% and 28% respectively, citing …

PHI main company
Sharemaestro market context Price below Trend Line 52 weeks -9.5% PHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ArcelorMittal Kryvyi Rih Hit by Missile Attack: Production Partially Halted

ArcelorMittal Kryvyi Rih, a Ukraine-based steel producer, reported that a missile attack on its facility resulted in two deaths and 13 injuries, damaging energy and blast furnace production units and causing a partial suspension of operations. The company is assessing the damage and condemned …

MT main company
Sharemaestro market context Trend signal active 52 weeks +119.7% · Next-week setup positive 58.0% MT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barclays cuts share count as buy-back tops 36 million shares

Barclays has continued its share buy-back program, repurchasing and cancelling over 13 million ordinary shares in August 2026 at prices slightly above 510 pence per share. This ongoing program has seen a total of 36.5 million shares repurchased since late July, aiming to return …

BCS main company
Sharemaestro market context Trend signal active 52 weeks +39.1% · Next-week setup positive 67.3% BCS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Resilient argenx stock backed by new Phase 3 success in autoimmune myositis

Argenx (ARGX) stock is gaining attention due to positive topline results from its Phase 3 ALKIVIA trial for efgartigimod in autoimmune myositis, expanding the drug's potential beyond existing indications. This clinical milestone reinforces the company's multi-billion dollar market capitalization and diverse pipeline, with investors …

ARGX main company
Sharemaestro market context Trend signal active 52 weeks +29.0% · Next-week setup positive 56.3% ARGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PLDT looks south for biggest data center site in PH

PLDT Inc.'s data center arm, Vitro Inc., is considering southern Luzon for its next major data center expansion, aiming for a 100 MW facility, which would be the largest in the Philippines. This strategic move is driven by the region's suitable power and water …

PHI main company
Sharemaestro market context Price below Trend Line 52 weeks -9.5% PHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Weekly Recap: Turnaround with $1B cuts and Analyst PT increases

Diageo plc (DGE) is implementing a $1 billion turnaround strategy involving brand refreshes and cost reductions. Despite facing regulatory challenges in India, including a court case over a ban on some of its brands and the seizure of bottles due to missing PET markings, …

DEO main company
Sharemaestro market context Price above Trend Line 52 weeks -14.3% DEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AMD’s 6.4% week stands out in semiconductors while participation drops to 0.7x

Advanced Micro Devices beat both Technology and semiconductor peers for the week, yet negative activity pressure and below-average volume keep the Sharemaestro read balanced rather than fully confirmed.

AMD main company
Sharemaestro market context Trend signal active 52 weeks +206.6% · Next-week setup positive 61.3% AMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

argenx SE Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; consistent treatment effect across IMNM and DM First Phase 3 …

ARGX main company
Sharemaestro market context Trend signal active 52 weeks +29.0% · Next-week setup positive 56.3% ARGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ukraine's largest steel plant partially halts operations after deadly Russian missile strike

A Russian missile attack on ArcelorMittal Kryvyi Rih, Ukraine's largest steel plant, killed two people and injured 13 others, forcing a partial halt in operations. The attack damaged key facilities for energy and blast-furnace operations. The company condemned the strike, emphasizing its civilian nature, …

MT main company
Sharemaestro market context Trend signal active 52 weeks +119.7% · Next-week setup positive 58.0% MT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ArcelorMittal Ukraine plant hit by Russian missiles as attacks intensify

Billionaire Lakshmi Mittal's ArcelorMittal steel plant in Ukraine's Kryvyi Rih was hit by Russian missiles, killing two people and injuring 14. The attack damaged power generation and blast furnace operations, partially halting production at Ukraine's largest steelmaker. This incident is part of an escalation …

MT main company
Sharemaestro market context Trend signal active 52 weeks +119.7% · Next-week setup positive 58.0% MT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Advanced Micro Devices (AMD) Is Up 6.4% After Record $4.75 Billion Bond Sale For AI Expansion

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Advanced Micro Devices (NasdaqGS: AMD) is preparing a multi billion dollar investment grade bond …

AMD main company AMD main company
Sharemaestro market context Trend signal active 52 weeks +198.5% · Next-week setup positive 63.2% AMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AMD (AMD) Stock Trades Up, Here Is Why

AMD (AMD) Stock Trades Up, Here Is Why What Happened? Shares of computer processor maker AMD (NASDAQ:AMD) jumped 5.1% in the afternoon session after the company priced a $4.75 billion bond offering to fund its expansion into the artificial intelligence and data center markets, …

AMD main company AMD main company AMD main company AMD main company AMD main company AMD main company
Sharemaestro market context Trend signal active 52 weeks +260.8% AMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

James Hardie faces shareholder class action over FY26 guidance after 34% share price fall

James Hardie Industries plc (ASX: JHX) is facing a shareholder class action in the Supreme Court of Victoria. The class action, filed by Slater and Gordon Lawyers, alleges that James Hardie made misleading representations regarding its FY26 earnings guidance, which led to a 34% …

JHX main company
Sharemaestro market context Trend signal active 52 weeks +51.3% JHX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IRMD Financials: Revenue Breakdown, Margins & Competitor Comparison

This article provides a financial overview of IRADIMED CORPORATION (IRMD), detailing its revenue breakdown, profitability margins, and a comparison with competitors. The company's main revenue source is MRI Compatible Patient Vital Signs Monitoring Systems, and it boasts strong gross, operating, and net margins, alongside …

IRMD main company
Sharemaestro market context Price below Trend Line 52 weeks +21.1% · Next-week setup positive 59.7% IRMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

James Hardie Industries Issues 141,354 Unquoted Ordinary Shares Linked to AZEK Merger Equity Awards

James Hardie Industries PLC (ASX:JHX) has announced the issuance of 141,354 unquoted ordinary shares (JHXAM) at USD 0.6806 per share. These shares are part of the settlement for equity awards related to its merger with The AZEK Company Inc., which was finalized on July …

JHX main company
Sharemaestro market context Trend signal active 52 weeks +51.3% JHX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NIO Stock Suffers Worst Run In 3 Weeks — Morningstar Sees 2027 Profit Even As China EV Price War Rages

Morningstar predicts Nio could achieve profitability by 2027 with $348 million in net profit, despite ongoing cash burn for the next couple of years. The research firm values NIO with a $6.50 fair value estimate, implying a 44% upside, but cautions about "Very High" …

NIO main company
Sharemaestro market context Price below Trend Line 52 weeks -28.7% NIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Radiopharm Theranostics (ASX:RAD) Sets October FDA Meeting as RAD101 Moves Toward Phase 3

Radiopharm Theranostics has scheduled an End-of-Phase 2 meeting with the U.S. FDA for October 1, 2026, to discuss the Phase 3 trial design for its imaging agent, RAD101. This comes after RAD101 achieved 93% concordance between MRI and PET imaging in its Phase 2b …

RADX main company
Sharemaestro market context Price below Trend Line 52 weeks -54.9% · Next-week setup negative 44.4% RADX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lloyds Banking Group PLC (NYSE:LYG) Short Interest Update

Lloyds Banking Group (NYSE:LYG) experienced a significant 49.3% drop in short interest in July, with holdings decreasing to 1.66 million shares. Despite slightly missing earnings and revenue expectations for the last quarter, analysts maintain a "Moderate Buy" consensus rating for the stock. The company …

LYG main company
Sharemaestro market context Trend signal active 52 weeks +38.3% · Next-week setup positive 62.2% LYG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context